Related Experiment Video
Updated: May 1, 2026

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
Published on: August 18, 2023
The future belongs to those who believe in multiplex CAR T engineering
Laura Volta1, Chiara F Magnani1
1Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Abstract:
Toxicity and immune evasion have hindered the success of CAR T cells in HER2-positive solid tumors. In this issue of Cell Stem Cell, Hosking et al. present an iPSC-derived CAR T cell product engineered for tumor-selective targeting, resistance to the immunosuppressive tumor microenvironment, enhanced persistence and trafficking, and mitigation of antigen escape.
Insights
Engineered induced pluripotent stem cell-derived CAR T cells overcome toxicity and immune evasion, improving treatment for HER2-positive solid tumors by enhancing tumor targeting and persistence.
Area of Science:
- Oncology
- Immunotherapy
- Stem Cell Biology
Background:
- CAR T-cell therapy faces challenges in HER2-positive solid tumors due to toxicity and immune evasion.
- Existing treatments are limited by the tumor microenvironment and antigen escape.
Purpose of the Study:
- To develop an induced pluripotent stem cell (iPSC)-derived CAR T-cell product for improved solid tumor treatment.
- To engineer CAR T cells for tumor-selective targeting, enhanced persistence, and overcoming immune evasion.
Main Methods:
- Generation of iPSC-derived CAR T cells.
- Engineering for tumor-specific antigen recognition.
- Enhancement of resistance to the immunosuppressive tumor microenvironment.
- Optimization for improved cell persistence and trafficking.
Main Results:
- The engineered iPSC-derived CAR T cells demonstrated tumor-selective targeting.
- Enhanced resistance to the immunosuppressive tumor microenvironment was observed.
- Improved cell persistence and trafficking within the tumor were achieved.
- Mitigation of antigen escape was a key outcome.
Conclusions:
- iPSC-derived CAR T cells offer a promising platform for overcoming challenges in solid tumor immunotherapy.
- This engineered cell product shows potential for more effective treatment of HER2-positive solid tumors.
Related Concept Videos
Design Example: Automobile Ignition System
One can generate a large voltage using a car battery of 12 volts with the help of inductors. Inductors are known for opposing...
Design of Transmission Shafts
Control Systems: Applications
In modern vehicles, control systems manage various functions to enhance performance and safety. The steering wheel and accelerator are primary inputs in a car's control system. The...
Electro-mechanical Systems
A key component of the DC motor is the armature, a rotating circuit positioned within a magnetic field. As an electric current passes through the...
Multi-input and Multi-variable systems
In the absence of...
Transformers in Distribution System
Distribution substation transformers come in various ratings and typically use mineral oil for insulation and cooling. To prevent moisture and air from entering the oil, some transformers use an inert gas like nitrogen to fill the...

